Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BOSTON SCIENTIFIC CORPORATION

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Prospective Single Arm Open Label Study of the FARAPULSE Pulsed Field Ablation System in Subjects with Persistent Atrial Fibrillation

Not Applicable

Active, not recruiting

Conditions: Persistent Atrial Fibrillation

First Posted Date: 2022-07-05

Last Posted Date: 2025-01-22

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 669

Registration Number: NCT05443594

Locations: 🇺🇸
Grandview Medical Center-Hospital, Birmingham, Alabama, United States
🇺🇸
Banner University Medical Center Phoenix-Hospital, Phoenix, Arizona, United States
🇺🇸
Arrhythmia Research Group-Research Facility, Jonesboro, Arkansas, United States

and more 41 locations

SpaceOAR System RWS in China

Not Applicable

Completed

Conditions: Localized T1-T2 Prostate Cancer

Interventions: Device: SpaceOAR Treatment

First Posted Date: 2022-06-07

Last Posted Date: 2025-06-26

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 15

Registration Number: NCT05407714

Locations: 🇨🇳
Boao First Life Care Center-Hospital, Qionghai, Hainan, China

A Pilot Study to Assess WATCHMAN FLX™ Implants by Cardiac Computed Tomography, Magnetic Resonance Imaging and Transesophageal Echocardiography: WATCHMAN FLX™ CT

Not Applicable

Completed

Conditions: The Focus of the Study is to Reduce the Risk of Stroke and Life-threatening Bleeding Events in Patients With Non-valvular Atrial Fibrillation

Interventions: Device: Watchman FLX Device

First Posted Date: 2022-04-12

Last Posted Date: 2025-04-30

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 25

Registration Number: NCT05324371

Locations: 🇩🇰
Aarhus University Hospital, Aarhus, Denmark

Varithena Versus Endothermal Ablation of the Great Saphenous Vein (VERITAS)

Phase 4

Terminated

Conditions: Varicose Veins

Interventions: Drug: Varithena®
Device: FDA-approved Endothermal Ablation (ETA) systems

First Posted Date: 2022-04-06

Last Posted Date: 2024-08-26

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 43

Registration Number: NCT05312970

Locations: 🇺🇸
Vascular Care Connecticut, Darien, Connecticut, United States
🇺🇸
Medstar Georgetown University Hospital, Washington, District of Columbia, United States
🇺🇸
Cardiovascular Institute of the South, Houma, Louisiana, United States

and more 6 locations

A Study to Evaluate the Effect of Spinal Cord Stimulation (SCS) on Painful Diabetic Peripheral Neuropathy (pDPN)

Not Applicable

Active, not recruiting

Conditions: Chronic Pain

Interventions: Device: Spinal Cord Stimulation (SCS)

First Posted Date: 2022-03-31

Last Posted Date: 2025-06-11

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 28

Registration Number: NCT05302063

Locations: 🇪🇸
Hospital La Paz, Madrid, Spain

A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM

Phase 1

Recruiting

Conditions: Glioblastoma Multiforme
Recurrent Glioblastoma

Interventions: Device: TheraSphere GBM

First Posted Date: 2022-03-31

Last Posted Date: 2025-06-27

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 36

Registration Number: NCT05303467

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
🇺🇸
University of California San Francisco, San Francisco, California, United States
🇺🇸
Mayo Jacksonville, Jacksonville, Florida, United States

and more 3 locations

POLARx™ Cardiac Cryoablation System Post Market Clinical Study (POLAR SMART)

Completed

Conditions: Paroxysmal Atrial Fibrillation

Interventions: Device: Boston Scientific Cardiac Cryoablation System

First Posted Date: 2022-03-16

Last Posted Date: 2025-05-31

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 295

Registration Number: NCT05282823

Locations: 🇯🇵
Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya-shi, Aichi, Japan
🇯🇵
Hirosaki University Hospital, Hirosaki-shi, Aomori, Japan
🇯🇵
Chiba University Hospital, Chiba-shi, Chiba-ken, Japan

and more 16 locations

TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.

Completed

Conditions: Hepatocellular Carcinoma

Interventions: Device: Technetium-99m macroaggregated albumin (Tc-99m MAA)

First Posted Date: 2022-02-10

Last Posted Date: 2025-03-06

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 6

Registration Number: NCT05233098

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

ACURATE Prime XL Human Feasibility Study

Not Applicable

Completed

Conditions: Aortic Stenosis

Interventions: Device: ACURATE Prime XL Transfemoral Aortic Valve System

First Posted Date: 2022-02-04

Last Posted Date: 2023-06-15

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 13

Registration Number: NCT05224245

Locations: 🇦🇺
Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
🇦🇺
The Prince Charles Hospital, Brisbane, Queensland, Australia
🇦🇺
Monash Health, Clayton, Victoria, Australia

CLBP Single-Arm Long-Term Follow-up Study

Completed

Conditions: Chronic Low Back Pain

Interventions: Device: Intracept Procedure

First Posted Date: 2022-01-26

Last Posted Date: 2025-05-08

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 42

Registration Number: NCT05207813

Locations: 🇺🇸
Indiana Spine Group, Carmel, Indiana, United States
🇺🇸
Seton Healthcare Family, Austin, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy